Update Venetoclax in CLL
Obinutuzumab
Acalabrutinib
Zanubrutinib
NCCN Guidelines for Patients for CLL
UpToDate
ASH: COVID-19 Resources for Managing Blood Cancers
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic